|Table of Contents|

Research progress on the correlation between asymptomatic pyuria and prognosis of urothelial cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 01
Page:
155-158
Research Field:
Publishing date:

Info

Title:
Research progress on the correlation between asymptomatic pyuria and prognosis of urothelial cancer
Author(s):
XU Xi1; ZENG Shuxiong1; ZHANG Zhensheng1; WANG Jialin2; XU Chuanliang1
1.Department of Urology；2.Department of Special Diagnosis and Treatment,Changhai Hospital,Naval Medical University,Shanghai 200433,China.
Keywords:
asymptomatic pyuria; inflammatory response; urothelial carcinoma; therapy; prognostic
PACS:
R737
DOI:
10.3969/j.issn.1672-4992.2024.01.029
Abstract:
The inflammation response plays an important role in the promotion,occurrence and development of cancers.Asymptomatic pyuria(AP),considered to be reflect the state of the urinary tract inflammation index,is closely related with the prognosis of urothelial carcinoma(UC).Recent researchs show that the changes of AP affect tumor microenvironment and local inflammatory reaction,which can be used to predict recurrence,treatment and disease progression of UC.In this paper,we systematically reviewed the relevant literatures on the critical value and mechanism of action of AP,as well as its prognostic value for upper tract urothelial carcinoma and bladder cancer in recent years,to evaluate the potential of AP as an effective prognostic indicator for UC therapy.

References:

［1］SIEGEL RL,MILLER KD,FUCHS HE,et al.Cancer statistics,2022［J］.CA Cancer J Clin,2022,72(1):7-33.
［2］ROUPRET M,BABJUK M,BURGER M,et al.European association of urology guidelines on upper urinary tract urothelial carcinoma:2020 update［J］.Eur Urol,2021,79(1):62-79.
［3］PAOLINO G,DI NICOLA MR,CURRADO M,et al.Serum tryptase levels in patients with psoriasis:A pilot study for a possible useful biomarker［J］.Clin Exp Dermatol,2022,47(1):178-179.
［4］HOOTON TM,ROBERTS PL,STAPLETON AE.Asymptomatic bacteriuria and pyuria in premenopausal women［J］.Clin Infect Dis,2021,72(8):1332-1338.
［5］AYAZI P,MAHYAR A,DANESHI MM,et al.Diagnostic accuracy of the quantitative C-reactive protein,erythrocyte sedimentation rate and white blood cell count in urinary tract infections among infants and children［J］.Malays J Med Sci,2013,20(5):40-46.
［6］TAN NC,KOONG AYL,NG LP,et al.Accuracy of urinary symptoms and urine microscopy in diagnosing urinary tract infection in women［J］.Fam Pract,2019,36(4):417-424.
［7］VEILLETTE JJ,WATERS CD,GELMAN SS,et al.Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departments［J］.Am J Emerg Med,2021,40:1-5.
［8］CAI T,VERZE P,BRUGNOLLI A,et al.Adherence to european association of urology guidelines on prophylactic antibiotics:An important step in antimicrobial stewardship［J］.Eur Urol,2016,69(2):276-283.
［9］FUKUSHIMA H,KOBAYASHI M,KAWANO K,et al.Effect of preoperative bacteriuria and pyuria on intravesical recurrence in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy［J］.In Vivo,2017,31(6):1215-1220.
［10］KISHIMOTO N,TAKAO T,KURIBAYASHI S,et al.The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy［J］.Int J Clin Oncol,2017,22(1):153-158.
［11］VARTOLOMEI MD,FERRO M,CANTIELLO F,et al.Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non-muscle-invasive bladder cancer［J］.Clin Genitourin Cancer,2018,16(6):445-452.
［12］TANG X,DU P,YANG Y.The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients:A systematic review and Meta-analysis［J］.Int J Clin Oncol,2017,22(5):817-825.
［13］HERR H,DONAT SM.Commentary:Does asymptomatic bacteriuria reduce the risk of recurrence of non-muscle-invasive bladder tumors［J］.Urology,2016,98:1-3.
［14］SATAKE N,OHNO Y,NAKASHIMA J,et al.Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer［J］.Int J Urol,2015,22(7):645-649.
［15］WANG R,YAN Y,LIU S,et al.Comparison of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios in bladder cancer patients undergoing radical cystectomy［J］.Biomed Res Int,2019,2019:3628384.
［16］TOPKAN E,MERTSOYLU H,KUCUK A,et al.Low systemic inflammation response index predicts good prognosis in locally advanced pancreatic carcinoma patients treated with concurrent chemoradiotherapy［J］.Gastroenterol Res Pract,2020,2020:5701949.
［17］AUDENET F,FARKAS AM,ANASTOS H,et al.Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer［J］.World J Urol,2018,36(11):1741-1748.
［18］MATSUMURA E,KOSUGE N,NAKANISHI S,et al.Urine lactoferrin as a potential biomarker reflecting the degree of malignancy in urothelial carcinoma of the bladder［J］.Tohoku J Exp Med,2020,252(3):225-244.
［19］AUDISIO A,BUTTIGLIERO C,DELCURATOLO MD,et al.New perspectives in the medical treatment of non-muscle-invasive bladder cancer:Immune checkpoint inhibitors and beyond［J］.Cells,2022,11(3):357.
［20］POLETAJEW S,GAJEWSKA D,KACZMAREK K,et al.Preoperative pyuria predicts the presence of high-grade bladder carcinoma in patients with bladder tumors［J］.Cent European J Urol,2020,73(4):423-436.
［21］SAZUKA T,SAKAMOTO S,IMAMURA Y,et al.Relationship between post-void residual urine volume,preoperative pyuria and intravesical recurrence after transurethral resection of bladder carcinoma［J］.Int J Urol,2020,27(11):1024-1030.
［22］KIM BS,TAE BS,KU JH,et al.Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor［J］.Investig Clin Urol,2018,59(1):10-17.
［23］BILBAO M,SPANIOL A,BEARSS J,et al.Histology surrounding cystotomy healing in a Sprague-Dawley rat model［J］.Int Urogynecol J,2014,25(1):97-101.
［24］BABJUK M,BURGER M,COMPERAT EM,et al.European association of urology guidelines on non-muscle-invasive bladder cancer(TaT1 and carcinoma in situ)-2019 update［J］.Eur Urol,2019,76(5):639-657.
［25］LI R,KAMAT AM.Predictors of response to intravesical therapy［J］.Urol Clin North Am,2020,47(1):23-33.
［26］SUH J,JUNG JH,JEONG CW,et al.Clinical significance of pre-treated neutrophil-lymphocyte ratio in the management of urothelial carcinoma:A systemic review and Meta-analysis［J］.Front Oncol,2019,9:1365.
［27］FABA OR,PISANO F,KRAJEWSKI W,et al.Salvage therapies for non-muscle-invasive bladder cancer:Who will respond to bacillus calmette-guerin predictors and nomograms［J］.Urol Clin North Am,2020,47(1):5-13.
［28］KARDOUST PARIZI M,SHARIAT SF,MARGULIS V,et al.Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer:A systematic review and Meta-analysis［J］.BJU Int,2021,127(6):617-625.
［29］SUH J,YUK HD,JEONG CW,et al.Pyuria as a predictive marker of Bacillus Calmette-Guerin unresponsiveness in non-muscle invasive bladder cancer［J］.J Clin Med,2021,10(17):3764.
［30］AZUMA T,NAGASE Y,OSHI M.Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin［J］.Mol Clin Oncol,2015,3(5):1113-1116.
［31］WITJES JA,BRUINS HM,CATHOMAS R,et al.European association of urology guidelines on muscle-invasive and metastatic bladder cancer:Summary of the 2020 guidelines［J］.Eur Urol,2021,79(1):82-104.
［32］HU G,XU F,ZHONG K,et al.The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy:A Meta-analysis［J］.World J Urol,2019,37(9):1817-1825.
［33］SAZUKA T,SAKAMOTO S,NAKAMURA K,et al.Impact of post-void residual urine volume on intravesical recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma［J］.Int J Urol,2019,26(12):1106-1112.
［34］LIANG C,WANG J,LIU H,et al.Preoperative pyuria predicts advanced pathologic tumor stage and worse survival in patients with urothelial carcinoma of the upper urinary tract treated by radical nephroureterectomy［J］.Urol Oncol,2016,34(9):e411-e418.
［35］YOSHIDA T,KINOSHITA H,SHIMADA S,et al.Preoperative pyuria is a poor prognostic factor in patients with urothelial carcinoma of the upper urinary tract after surgery［J］.Clin Genitourin Cancer,2017,15(4):e543-e550.
［36］SATO G,YOSHIDA T,YANISHI M,et al.Preoperative pyuria predicts for intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract after radical nephroureterectomy without a history of bladder cancer［J］.Clin Genitourin Cancer,2020,18(2):e167-e173.
［37］MILOJEVIC B,DZAMIC Z,BOJANIC N,et al.Urothelial carcinoma of the upper urinary tract:Preoperative pyuria is not correlated with bladder cancer recurrence and survival［J］.Int Urol Nephrol,2019,51(5):831-838.
［38］JEON BJ,TAE BS,CHOI H,et al.Preoperative sterile pyuria as a prognostic biomarker for intravesical recurrence in upper urinary tract urothelial carcinoma［J］.Investig Clin Urol,2020,61(1):51-58.
［39］YUAN H,CHEN X,LIU L,et al.Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma:A Meta-analysis［J］.Urol Oncol,2014,32(7):989-1002.
［40］MILOJEVIC B,DZAMIC Z,GROZDIC MILOJEVIC I,et al.Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy:A cohort study［J］.Urol Oncol,2021,39(7):e789.

Memo

Memo:
海军军医大学“深蓝”人才工程“远航”人才计划（编号：2021）
Last Update: 2023-11-30